The global artificial cervical disc market is driven by several factors, such ast he increasing prevalence of orthopedic diseases and degenerative diseases, technological advancements in artificial discs, and the rise of a geriatric population in developed and developing economies. In addition, the artificial cervical disc market is anticipated to grow during the forecast period due to the rising healthcare expenditure, supportive reimbursement, growing acceptance of implantation, increasing disposable income, and increasing investments in healthcare infrastructure by the government and private sectors.
Many market players are dominating the global artificial cervical disc market. The prominent players are involved in strategic agreements, product launches, acquisitions, and joint ventures to sustain their market positions. For instance,in February 2021, NuVasive Inc. (US) acquired Simplify MedicalInc. (US), This acquisition expanded NuVasive’s cervical portfolio by providing the most clinically effective cTDR technology, and further distinguishes NuVasive’s cervical portfolio.
According to MRFR analysis, the global artificial cervical disc market is expected to register a CAGR of ~19% from 2021 to 2027 and hold a value of ~USD 6,262.1 million by 2027.
Furthermore, artificial cervical disc replacement in Europe will turn out to be one of the most sought-after medical procedures by medical tourists. Cost-effective and excellent medical care offered by the European spine surgeons and increasing investment in the RD sector is also fueling the market growth in this region.
Asia-Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on health care, large population, improving economy, and growing medical tourism in developing nations such as China, Japan, and India in this region
Furthermore, the growth of the market in the Rest of the World is attributed to rapidly improving healthcare infrastructure, technological development, healthcare management, and hospital management. Government initiatives for improving the healthcare sector are another factor boosting the growth of the market in this region.
The artificial cervical disc market is segmented on the basis of product type, material, end user, and region.
Based on product type, the artificial cervical disc market is categorized into cervical disc and lumbar disc. The cervical disc segment held a significant market share in 2020.The rising prevalence of degenerative disc disease and the growing demand for non-invasive procedures are the key driving factors of the artificial cervical disc segment.
Based on material, the artificial cervical disc market is classified into metal-on-metal and metal-on-biopolymer. The metal-on-metal material segment is expected to attain significant revenue over the forecast period. Growing preference for metal implants by numerous healthcare practitioners, including surgeons, doctors, and clinicians. Moreover, metal implants requires considerably lower costs than metal-on-biopolymers.
Based on end user, the artificial cervical disc market can be segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment was the largest end user segment in 2020 due to the availability of skilled doctors, high efficacy rate, better treatment, and advancements in the hospital infrastructure.
Some of the key players in the global artificial cervical disc market are Globus Medical Inc (US), Zimmer Biomet Holdings Inc. (US), B. Braun Melsungen AG (Germany), Centinel Spine, LLC (Switzerland), Medtronic PLC (Ireland), Nuvasive Inc. (US), Johnson Johnson (US), Orthofix Company (US), Alphatec Spine (US), Simplify Medical (US), AxioMed (US), Aditus Medical (Germany), FH Orthopedics (France), Medicrea (France), and Spineart (Switzerland)